Literature DB >> 23046460

Radiolabeling of umbilical cord-derived mesenchymal stem cells for in vivo tracking.

Archana Mukherjee1, Shabari Tipnis, Haladhar Dev Sarma, Geeta Ravindran, Grace Samuel, Chandra Viswanathan, Meera Venkatesh.   

Abstract

Non-invasive methods for the assessment of distribution, homing, and retention of stem cells are desired for the successful demonstration of stem cell therapy. Cells labeled with (99m)Tc, (18)F, and (111)In have been reported for tracking the cells in vivo. However, they can be tracked only for a limited time due to the short half lives of these isotopes. In this context, stem cells labeled with (51)Cr would be appropriate for tracking cells for a longer period of time owing to their half life of 27.7 days. Here, we have isolated mesenchymal stem cells (MSCs) from umbilical cord tissue, characterized them, and attempted to radiolabel them with (51)Cr for mapping the fate of transplanted MSC cells after an intravenous injection via the tail vein in small animals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23046460     DOI: 10.1089/cbr.2011.1146

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  7 in total

Review 1.  Beyond chimerism analysis: methods for tracking a new generation of cell-based medicines.

Authors:  Joaquim Vives; Aina Casademont-Roca; Lluís Martorell; Núria Nogués
Journal:  Bone Marrow Transplant       Date:  2020-02-05       Impact factor: 5.483

Review 2.  Practical Issues with the Use of Stem Cells for Cancer Gene Therapy.

Authors:  Faranak Salman Nouri; Debabrata Banerjee; Arash Hatefi
Journal:  Stem Cell Rev Rep       Date:  2015-10       Impact factor: 5.739

3.  In vivo tracking of human placenta derived mesenchymal stem cells in nude mice via ¹⁴C-TdR labeling.

Authors:  Cheng-Guang Wu; Ji-Chun Zhang; Cheng-Quan Xie; Ornella Parolini; Antonietta Silini; Yi-Zhou Huang; Bing Lian; Min Zhang; Yong-Can Huang; Li Deng
Journal:  BMC Biotechnol       Date:  2015-06-13       Impact factor: 2.563

4.  In vivo tracking of 14C thymidine labeled mesenchymal stem cells using ultra-sensitive accelerator mass spectrometry.

Authors:  Min-Seok Oh; Seul-Gi Lee; Gwan-Ho Lee; C-Yoon Kim; Eun-Young Kim; Jong Han Song; Byung-Yong Yu; Hyung Min Chung
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

Review 5.  Wharton's jelly-derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation.

Authors:  Cécile Pochon; Anne-Béatrice Notarantonio; Caroline Laroye; Loic Reppel; Danièle Bensoussan; Allan Bertrand; Marie-Thérèse Rubio; Maud D'Aveni
Journal:  J Cell Mol Med       Date:  2022-01-28       Impact factor: 5.310

Review 6.  Intravenously Infused Stem Cells for Cancer Treatment.

Authors:  Alison R Mercer-Smith; Ingrid A Findlay; Hunter N Bomba; Shawn D Hingtgen
Journal:  Stem Cell Rev Rep       Date:  2021-06-17       Impact factor: 5.739

7.  Dynamic Imaging of Marrow-Resident Granulocytes Interacting with Human Mesenchymal Stem Cells upon Systemic Lipopolysaccharide Challenge.

Authors:  Jay T Myers; Deborah S Barkauskas; Alex Y Huang
Journal:  Stem Cells Int       Date:  2013-03-27       Impact factor: 5.443

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.